Prempro
NDC Package 50090-0573-0
Package Information
Prempro is or PREMPHASE therapy should not be used in women with any of the following conditions:Undiagnosed abnormal genital bleedingKnown, suspected, or history of breast cancerKnown or suspected estrogen-dependent neoplasiaActive DVT, PE, or a history of these conditionsActive arterial thromboembolic disease (for example, stroke and MI), or a history of these conditionsKnown anaphylactic reaction or angioedema to PREMPRO/PREMPHASEKnown liver dysfunction or diseaseKnown protein C, protein S, or antithrombin deficiency, or other known thrombophilic disorders Known or suspected pregnancy. Marketed by A-s Medication Solutions, this product is identified by NDC 50090-0573 and is authorized under FDA application NDA020527.
Identification & Billing
- RxCUI: 1000355 - estrogens, conjugated 0.625 MG / medroxyPROGESTERone acetate 2.5 MG Oral Tablet
- RxCUI: 1000355 - estrogens, conjugated (USP) 0.625 MG / medroxyprogesterone acetate 2.5 MG Oral Tablet
- RxCUI: 1000395 - {28 (estrogens, conjugated (USP) 0.625 MG / medroxyprogesterone acetate 2.5 MG Oral Tablet) } Pack
- RxCUI: 1000395 - Estrogens Conj-Medroxyprogest Ac 0.625-2.5 MG (28) Oral Tablet 28 Day Pack
- RxCUI: 1000499 - {28 (estrogens, conjugated (USP) 0.625 MG / medroxyprogesterone acetate 2.5 MG Oral Tablet) } Pack [Prempro 0.625/2.5 28 Day]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 50090 - A-s Medication Solutions
- 50090-0573 - Prempro
- 50090-0573-0 - 1 BLISTER PACK in 1 CARTON / 28 TABLET, SUGAR COATED in 1 BLISTER PACK
- 50090-0573 - Prempro
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 50090-0573-0 identifies a specific commercial package of 1 blister pack in 1 carton / 28 tablet, sugar coated in 1 blister pack of Prempro, labeled by A-s Medication Solutions. This product is billed for "EA" each discreet unit and contains an estimated amount of 28 billable units per package. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by A-s Medication Solutions on September 21, 2009. The current certification is valid through December 31, 2022.
How is this A-s Medication Solutions product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 50090057300. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 28 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.